HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway

被引：0
|
作者：
Jiancheng Lv
Kai Li
Hao Yu
Jie Han
Juntao Zhuang
Ruixi Yu
Yidong Cheng
Qiang Song
Kexin Bai
Qiang Cao
Haiwei Yang
Xiao Yang
Qiang Lu
机构：
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Urology
来源：
Journal of Experimental & Clinical Cancer Research | / 42卷
关键词：
circFAM13B; Bladder cancer; IGF2BP1; PKM2; Glycolysis; Immunosensitivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
  • [1] HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway
    Lv, Jiancheng
    Li, Kai
    Yu, Hao
    Han, Jie
    Zhuang, Juntao
    Yu, Ruixi
    Cheng, Yidong
    Song, Qiang
    Bai, Kexin
    Cao, Qiang
    Yang, Haiwei
    Yang, Xiao
    Lu, Qiang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [2] HNRNPL INDUCED CIRCFAM13B INCREASED BLADDER CANCER IMMUNOTHERAPY SENSITIVITY VIA INHIBITING GLYCOLYSIS THROUGH IGF2BP1/PKM2 PATHWAY
    Lv, Qiang
    Yang, Xiao
    Cao, Qiang
    Lv, Jiancheng
    JOURNAL OF UROLOGY, 2023, 209 : E188 - E188
  • [3] Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting 13-catenin signaling pathway
    Yu, Wenna
    Zeng, Fuling
    Xiao, Yang
    Chen, Liuyan
    Qu, Hengdong
    Hong, Jian
    Qu, Chen
    Cheng, Guohua
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 387
  • [4] CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway
    Li, Kai
    Lv, Jiancheng
    Wang, Jun
    Wei, Yong
    Zhang, Yetao
    Lin, Jianzhong
    Zhu, Qingyi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [5] Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway
    Qin, Xuying
    Sun, Linlin
    Wang, Jing
    CELL BIOLOGY INTERNATIONAL, 2017, 41 (10) : 1110 - 1118
  • [6] Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer
    Wang, Lili
    Lyu, Chen
    Stadlbauer, Birgit
    Buchner, Alexander
    Noessner, Elfriede
    Pohla, Heike
    PROSTATE, 2024, 84 (02): : 131 - 147
  • [7] CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
    Xie, Fei
    Huang, Chao
    Liu, Feng
    Zhang, Hui
    Xiao, Xingyuan
    Sun, Jiayin
    Zhang, Xiaoping
    Jiang, Guosong
    MOLECULAR CANCER, 2021, 20 (01)
  • [8] CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
    Fei Xie
    Chao Huang
    Feng Liu
    Hui Zhang
    Xingyuan Xiao
    Jiayin Sun
    Xiaoping Zhang
    Guosong Jiang
    Molecular Cancer, 20
  • [9] Correction: CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
    Fei Xie
    Chao Huang
    Feng Liu
    Hui Zhang
    Xingyuan Xiao
    Jiayin Sun
    Xiaoping Zhang
    Guosong Jiang
    Molecular Cancer, 21
  • [10] Knockdown of UCA1 inhibits viability and glycolysis by suppressing PKM2 expression through the mTOR pathway in non-small cell lung cancer cells
    Wang, Xuguang
    Fa, Xian-En
    RSC ADVANCES, 2018, 8 (19) : 10610 - 10619
123